Re: A New Concept for Early Recovery After Surgery in Patients Undergoing Radical Cystectomy for Bladder Cancer: Results of a Prospective Randomized Study

2014 ◽  
Vol 66 (2) ◽  
pp. 392
Author(s):  
Nikhil Sapre ◽  
Declan G. Murphy
2014 ◽  
Vol 32 (1) ◽  
pp. 45.e11-45.e15 ◽  
Author(s):  
Ian M. Thompson ◽  
Stephen F. Kappa ◽  
Todd M. Morgan ◽  
Daniel A. Barocas ◽  
Carl J. Bischoff ◽  
...  

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Ian Thompson ◽  
Daniel Barocas ◽  
Carl Bischoff ◽  
Peter Clark ◽  
Michael Cookson ◽  
...  

1994 ◽  
Vol 35 (S1) ◽  
pp. S36-S40 ◽  
Author(s):  
Yoshihiko Hirao ◽  
Seiichiro Ozono ◽  
Hitoshi Momose ◽  
Eigoro Okajima ◽  
Tadashi Hiramatsu ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e16059-e16059
Author(s):  
J. Guillotreau ◽  
X. Gamé ◽  
M. Mouzin ◽  
N. Doumerc ◽  
B. Malavaud ◽  
...  

e16059 Background: To compare the oncological outcomes of laparoscopic versus open surgery in radical cystectomy for bladder cancer. Methods: A prospective non-randomized study was conducted between January 2003 and November 2008 in 52 patients, 2 women and 50 men, who underwent radical cystectomy for bladder cancer. Thirty seven cystectomies were carried out by laparoscopic surgery (LS) and 15 by open surgery (OS). Mean patient age was 67.3 ± 9.7 years. The median preoperative ASA score was 2 (1–3) in both groups. Kaplan-Meier curves were constructed to estimate the survival rate for the whole sample. Datas were compared by Log-rank test. Current followup, overall and specific deaths were used as endpoints. The survival time was defined as the time elapsed from the date of radical cystectomy to the endpoint. Results: All tumours were transitional cell carcinoma, high-grade and stage < pT3b pN0. One patient of OS group had a positive surgical margin. Eight patients (15.4%), 7 of LS group and 1 of OS group, completed 5 years of follow-up. At the last follow-up 40 patients (76.9%) were alive with no evidence of disease and 5 (9.6%) died, two patients (3.8%) from metastasis and 3 (5.7%) from different causes. No patient developed port- site metastasis. Overall survival was significantly better in LS group than in the OS group (p=0.039). No statistical difference was noted for Specific survival. Mean patient follow-up was 30.9 ± 20.3 months. Conclusions: The data suggest that LRC provides oncological outcomes comparable to contemporary series of open RC. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document